Suchergebnisse - "Otsubo, Naoya"

PubPharm (9)

1

Comparative outcomes of hemodialysis patients facing pre-Omicron and Omicron COVID-19 epidemics

enthalten in: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy | 2024

von Beppu, H. | Fukuda, T. | Otsubo, N. | +10

2

Comparative outcomes of hemodialysis patients facing pre‐ Omicron and Omicron COVID‐19 epidemics

enthalten in: Therapeutic Apheresis and Dialysis | 2024

von Beppu, H. | Fukuda, T. | Otsubo, N. | +10

3

Utility of Indices Obtained during Medical Checkups for Predicting Fatty Liver Disease in Non-obese People

enthalten in: Internal medicine (Tokyo, Japan) | 2023

von Otsubo, N. | Fukuda, T. | Cho, G. | +3

4

Association between Diabetic Peripheral Neuropathy as Measured Using a Point-of-Care Sural Nerve Conduction Device and Urinary Albumin Excretion in Patients with Type 2 Diabetes

enthalten in: Journal of clinical medicine | 2023

von Fukuda, T. | Fujii, A. | Akihisa, T. | +4

5

Serum chemokine CC-motif ligand 17 is a predictive marker of severe COVID-19 in haemodialysis patients : A retrospective observational study

enthalten in: Nephrology (Carlton, Vic.) | 2023

von Beppu, H. | Fukuda, T. | Otsubo, N. | +10

6

Reduced antibody response to SARS-CoV-2 in COVID-19 patients with newly diagnosed diabetes : a retrospective observational study

enthalten in: BMC endocrine disorders | 2023

von Otsubo, N. | Fukuda, T. | Beppu, H. | +8

7

Reduced antibody response to SARS-CoV-2 in COVID-19 patients with newly diagnosed diabetes: a retrospective observational study

enthalten in: BMC endocrine disorders | 2023

von Otsubo, N. | Fukuda, T. | Beppu, H. | +8

8

Reduced antibody response to SARS-CoV-2 in COVID-19 patients with newly diagnosed diabetes: a retrospective observational study

enthalten in: BMC endocrine disorders | 2023

von Otsubo, N. | Fukuda, T. | Beppu, H. | +8

9

Serum chemokine CC‐motif ligand 17 is a predictive marker of severe COVID‐19 in haemodialysis patients : A retrospective observational study

enthalten in: Nephrology | 2023

von Beppu, H. | Fukuda, T. | Otsubo, N. | +10

1
[1]